Our experimental model allowed us to compare the effect of different sclerotomy diameters (23G and 25G) on incisional mechanical resistance. This model has shown us some positive points. First, the use of the same tools and surgical procedures that are used in humans helped us simulate the real conditions we find in our usual surgical practice. Second, the use of pig eyes, which are very similar to human eyes and are easy to obtain, allowed us to include a great number of vitrectomized eyes. Third, the use of the VGFI of the vitrectomy system is an objective and quantitative method for the control of IOP included in the vitrectomy unit, so no new material was needed. Therefore, we can assume that this animal model, as well as allowing us to evaluate the effect of the different gauges on sclerotomy competency, may become the basis for future studies to evaluate the effect of other types of incisions or other surgical instruments on sclerotomy closure capability.
Despite the morphologic similarities between human eyes and pig eyes (as can be sees in
Fig. 7), the absolute IOP values at which sclerotomies showed leakage should not be considered the main conclusion of our study. Our clinical experience has shown us that in human eyes, the IOP level at which sutureless sclerotomy leaks is lower. The important outcome is the relative difference between the 23G and the 25G sclerotomy leakage values.
The conclusion of this study is that there is a significant difference in IOP level at which the different gauges first open. Thus, when changing from 25G to 23G vitrectomy, the surgeon has to assume an increase in the incidence of sclerotomy leakage. To obtain similar closure standards between both gauges, the surgeon should probably be prepared to perform more sclerotomy suturing with 23G vitrectomy.
The period during which the results of our study were valid in real clinical practice was limited to the time frame between the retrieval of the cannula and the development of the healing mechanisms because we only study mechanical resistance to increased IOP. No reparative mechanisms occurred in our experimental model because we used cadaveric eyes. This period has been established between the second and fifth days after sclerotomy
12 in experimental models of TSV vitrectomy. Other experimental models of scleral incisions offer similar results.
16 In humans, healing chronology in TSV has been established primarily through indirect imaging methods; ultrasound biomicroscopy and anterior segment optical coherence tomography (Visante; Carl Zeiss, Oberkochen, Germany) are the most frequently used methods. In these imaging studies, the moment healing began could not be well established; what could be established was when the process was completed, manifested by the disappearance of the incisional gap. In this sense, studies by Rizzo
17 established the healing period of oblique sclerotomies around 7 days. Other studies place this time frame between 7 and 15 days.
18
The fact that our study was applicable only during the few first preoperative days was no less important because studies related to post-TSV endophthalmitis place the mean postoperative day for infection appearance around the third day.
19,20 Thus, bacteria ingress can only have occurred during surgery or in the early postoperative days, when incision closure was primarily dependent on mechanical factors. India ink particles studies (whose size is similar to that of bacteria) have demonstrated postoperative ingress into the eye after straight sutureless sclerotomies in microincisional vitrectomy both in experimental
21 and in human cadaveric eyes.
22
The trocar used, as we have mentioned earlier, creates a V-shaped incision. We have not used new trocar designs for TSV (beveled at both sides) or two-step TSV systems (knife used for sclerotomy), each of which creates a slit-shaped sclerotomy. Series published using slit-shaped sclerotomies reveal better closure properties for both 25G
23 and 23G.
24 We do not know whether this change in incisional shape could make 23G sclerotomies as mechanically resistant as 25G sclerotomies to IOP increases.
Our study reports the development of an animal model that can be used to study sclerotomy closure properties. Based on this animal model, we have concluded that an increase in the sclerotomy diameter from 25G to 23G is related to less mechanical resistance when IOP is increased. These results may well be translated to human eye surgery. To achieve a similar closure rate between 25G and 23G TSV vitrectomy, surgeons should be prepared to perform a higher number of sutures on 23G oblique TSV sclerotomies.